Overview
Ibrahim Bayav practices practicing medicine in Pamukkale, Turkey.
Mr. Bayav is highly rated in 1 condition, according to our data. His clinical expertise encompasses Retinoblastoma, Breast Cancer, and Neurotoxicity Syndromes.
He is actively involved in clinical research, co-authoring 9 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Ibrahim Bayav
Is Ibrahim Bayav a top-rated expert for Retinoblastoma?
MediFind is an objective health platform that identifies experts based on real-world data. Ibrahim Bayav is classified as an Advanced expert for Retinoblastoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Ibrahim Bayav participate in research or clinical trials?
Yes. Ibrahim Bayav has published 9 articles and abstracts on conditions like Retinoblastoma. You can view a list of Ibrahim Bayav's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- RetinoblastomaMr. Bayav isAdvanced. Learn about Retinoblastoma.
- Experienced
- Breast CancerMr. Bayav isExperienced. Learn about Breast Cancer.
- Neurotoxicity SyndromesMr. Bayav isExperienced. Learn about Neurotoxicity Syndromes.